Reported Reactions

Adverse event reports that FDA received

  • Search
  • Watch list

Grip strength decreased adverse event reports that record this term

Kind of term
MedDRA preferred term

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on . The data have the reports that FDA received through .

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.

Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on .

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports on file

From February 2004 to June 2026, FDA received 8,631 adverse event reports that record the MedDRA preferred term Grip strength decreased. The person who codes a report selects the term that agrees best with the description of the reporter.

FDA received 724 reports in the 12 months to June 2026 and 1,101 in the 12 months before. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

The number of people who use the product is not in the data. A count is not a rate.

MedDRA

The Medical Dictionary for Regulatory Activities. The person who codes a report selects the preferred term that agrees best with the description of the reporter. FDA does not publish the description.

Data version

openFDA FAERS release of 1 Oct 2026. Reports received through 30 Jun 2026.

Drugs in these reports

The table has the 121 drug pages with 250 or more reports that record this term. The rows are in order of name. A drug page with fewer reports for this term is not in the table. The counts are the counts that the site keeps for each reaction term, and a count can be lower than the count of FDA.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Drugs that the reports with the term Grip strength decreased name as a suspect product, in order of name
DrugClassReports with this term
Acetaminophen1,146
Acetaminophen and codeineOpioid agonist399
Acetaminophen Oxycodone Hydrochloride290
ActemraInterleukin-6 receptor antagonist1,617
AdalimumabTumor necrosis factor blocker1,304
Aimovig596
Alendronate sodiumBisphosphonate922
Alendronate Sodium Cholecalciferol473
Alendronic Acid807
ApremilastPhosphodiesterase 4 inhibitor690
AravaAntirheumatic agent1,205
AtomoxetineNorepinephrine reuptake inhibitor254
AzathioprinePurine antimetabolite533
Azathioprine sodiumPurine antimetabolite278
Berinert412
Botulinum toxin type aAcetylcholine release inhibitor407
ButransPartial opioid agonist410
Calcium308
Calcium Ascorbate328
Calcium carbonateBlood coagulation factor677
Calcium citrate250
Calcium Glubionate786
CandesartanAngiotensin 2 receptor blocker531
CelebrexNonsteroidal anti-inflammatory drug668
CelecoxibNonsteroidal anti-inflammatory drug592
Certolizumab pegolTumor necrosis factor blocker653
CetirizineHistamine-1 receptor antagonist605
Cetirizine hydrochlorideHistamine-1 receptor antagonist1,097
Cetirizine hydrochloride, pseudoephedrine hydrochlorideHistamine-1 receptor antagonist689
Chloraprep305
Chlorhexidine485
Chlorhexidine gluconate501
Chlorhexidine Gluconate Isopropyl Alcohol278
Cholecalciferol519
CimziaTumor necrosis factor blocker1,412
CortisoneCorticosteroid465
Cortisone acetateCorticosteroid893
CosentyxInterleukin-17A antagonist1,580
DesoximetasoneCorticosteroid1,215
DiclofenacNonsteroidal anti-inflammatory drug910
Diclofenac diethylamine624
Diclofenac potassiumNonsteroidal anti-inflammatory drug798
Diclofenac sodiumNonsteroidal anti-inflammatory drug1,577
Dietary Supplement Herbals291
Domperidone maleate361
DoxycyclineTetracycline-class drug251
Doxycycline hyclateTetracycline-class drug336
EnbrelTumor necrosis factor blocker2,442
EntyvioIntegrin receptor antagonist278
Erelzi1,349
ErgocalciferolProvitamin D2 compound587
EtanerceptTumor necrosis factor blocker296
Flumethasone349
Flumethasone Pivalate879
Folic acid1,437
FosamaxBisphosphonate1,096
GoldStandardized chemical allergen374
Gold Sodium Thiomalate517
GolimumabTumor necrosis factor blocker571
Humira2,225
HyaluronidaseEndoglycosidase256
HydrocortisoneCorticosteroid708
Hydrocortisone acetateCorticosteroid466
Hydrocortisone sodium succinateCorticosteroid276
HydroxychloroquineAntimalarial1,118
Hydroxychloroquine sulfateAntimalarial1,005
InfliximabTumor necrosis factor blocker1,230
Isopropyl alcoholStandardized chemical allergen597
KevzaraInterleukin-6 receptor antagonist659
LamictalAnti-epileptic agent409
LeflunomideAntirheumatic agent1,553
Lyrica443
MesalamineAminosalicylate266
MethotrexateFolate analog metabolic inhibitor2,203
Methotrexate sodiumFolate analog metabolic inhibitor414
MethylprednisoloneCorticosteroid338
Methylprednisolone sodium succinateCorticosteroid538
MinocyclineTetracycline-class drug286
Minocycline hydrochlorideTetracycline-class drug251
Mycophenolate mofetilAntimetabolite immunosuppressant542
Myochrysine301
Myrbetriqbeta3-Adrenergic agonist297
NaproxenNonsteroidal anti-inflammatory drug558
Naproxen sodiumNonsteroidal anti-inflammatory drug739
NucalaInterleukin-5 antagonist350
OrenciaSelective T cell costimulation modulator1,396
OtezlaPhosphodiesterase 4 inhibitor686
OxycodoneOpioid agonist766
Oxycodone hydrochlorideOpioid agonist383
Oxycodone Terephthalate624
PantoprazoleProton pump inhibitor407
Pantoprazole sodiumProton pump inhibitor309
Pantoprazole Sodium Anhydrous314
Periogard521
Phenylephrine hydrochloridealpha-1 adrenergic agonist451
Phthalylsulfathiazole1,059
PlaquenilAntimalarial650
PrednisoneCorticosteroid1,386
Pregabalin313
Pseudoephedrine531
Pseudoephedrine hydrochloridealpha-Adrenergic agonist775
RamiprilAngiotensin converting enzyme inhibitor586
RemicadeTumor necrosis factor blocker1,095
RinvoqJanus kinase inhibitor322
RituxanCD20-directed cytolytic antibody312
RituximabCD20-directed cytolytic antibody1,655
SimponiTumor necrosis factor blocker1,324
Sirukumab335
StelaraInterleukin-12 antagonist879
Sulfamethoxazole396
Sulfamethoxazole, trimethoprimDihydrofolate reductase inhibitor antibacterial422
SulfasalazineAminosalicylate1,534
TocilizumabInterleukin-6 receptor antagonist590
TofacitinibJanus kinase inhibitor384
Tofacitinib citrateJanus kinase inhibitor385
Topiramate450
Tramadol hydrochlorideOpioid agonist483
Triamcinolone acetonideCorticosteroid384
UstekinumabInterleukin-12 antagonist359
Vitamin cVitamin C517
XeljanzJanus kinase inhibitor1,344

The page of each drug has the count of each reaction term in its reaction lookup.

Drug classes in these reports

The table has the 52 pharmacologic classes with 100 or more reports that record this term. The rows are in order of name.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Pharmacologic classes of the drugs that the reports with the term Grip strength decreased name, in order of name
ClassReports with this term
Acetylcholine release inhibitor436
alpha-1 adrenergic agonist456
alpha-Adrenergic agonist775
Aminoglycoside antibacterial155
Aminosalicylate1,825
Angiotensin 2 receptor blocker642
Angiotensin converting enzyme inhibitor895
Anti-epileptic agent591
Antimalarial2,773
Antimetabolite immunosuppressant550
Antirheumatic agent2,758
Atypical antipsychotic409
Benzodiazepine271
beta2-Adrenergic agonist149
beta3-Adrenergic agonist318
Biguanide162
Bisphosphonate2,193
Blood coagulation factor903
Calcium channel blocker198
Calculi dissolution agent237
CD20-directed cytolytic antibody2,102
Central alpha-2 adrenergic agonist138
Central nervous system stimulant196
Copper-containing intrauterine device142
Corticosteroid7,504
Dihydrofolate reductase inhibitor antibacterial685
Endoglycosidase256
Folate analog metabolic inhibitor2,617
Histamine-1 receptor antagonist2,769
Histamine-2 receptor antagonist349
Integrin receptor antagonist340
Interleukin-12 antagonist1,238
Interleukin-17A antagonist1,698
Interleukin-5 antagonist362
Interleukin-6 receptor antagonist3,030
Janus kinase inhibitor2,450
l-Thyroxine116
Nonsteroidal anti-inflammatory drug6,402
Norepinephrine reuptake inhibitor500
Opioid agonist2,548
Partial opioid agonist503
Phosphodiesterase 4 inhibitor1,376
Proton pump inhibitor969
Provitamin D2 compound600
Purine antimetabolite918
Pyrimidine synthesis inhibitor104
Selective T cell costimulation modulator1,565
Standardized chemical allergen971
Substance P/Neurokinin-1 receptor antagonist292
Tetracycline-class drug1,124
Tumor necrosis factor blocker10,591
Vitamin C678

A class with many reports in all has many reports for almost every term.

Reports by month

Reports that record Grip strength decreased, by month, five years to June 2026
010020020222023202420252026

FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Patients in these reports

Age of the patient in the reports that record Grip strength decreased
AgeReportsShareShare as a bar
Under 280.1%
2 to 11190.2%
12 to 17300.3%
18 to 441,98123%
45 to 642,28526.5%
65 to 741,01311.7%
75 and over5616.5%
Age not given2,73431.7%
Sex of the patient in the reports that record Grip strength decreased
SexReportsShareShare as a bar
Female6,30873.1%
Male1,63919%
Unknown or not given6847.9%

Age and sex are as the report gives them. 47.1% of these reports give the United States as the country.

Terms near this one

Official pages

The site checked these addresses on . The links open in a new tab.

Cite this page

Reported Reactions. Grip strength decreased: adverse event reports that record this term. https://reportedreactions.com/reaction/grip-strength-decreased/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of . Reports received through .

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 1 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Oct 2026. A class is the pharmacologic class (EPC) of the FDA label.

The count has the reports with each spelling of one MedDRA preferred term. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

What does Grip strength decreased mean in an adverse event report?

It is a MedDRA preferred term. FDA codes the description of a reporter with the MedDRA dictionary. The openFDA files do not have the description itself, and this site does not show it.

Does a drug in the table mean that the drug was responsible for this reaction?

No. FDA says:

No individual drug is connected to any individual reaction.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

When a report lists multiple drugs and multiple reactions, there is no way to conclude from the data therein that a given drug is responsible for a given reaction.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

What does this page tell a person who has this symptom?

This page gives counts of reports. It cannot assess a person. A pharmacist or a clinician can assess a person.

If this is a medical emergency, please call 911.

Source: FDA, MedWatch Online Voluntary Reporting Form. The site read the page on .